Full-Text Search:
Home|About CNKI|User Service|中文
Add to Favorite Get Latest Update

The clinical research of chronic-obstructive pulmonary disease caused by Pneumoconiosis treated by Shuanghuanglian Injection in acute-exacerbated period

YUAN Cheng-xing,JIANG Cun-guo,HAN Juan,et al.Beisu Mine Hosopital Affiliated Yanzhou Coal Mine Group,Zoucheng273516,China  
Objective To investigate the therapeutic effect of Shuanghuanglian Injection on pneumoconiosis caused by chronic obstructive pulmonary disease(COPD) during the acute-exacerbated period.Methods120 cases of pneumoconiosis caused by chronic obstructive pulmonary disease in acute-exacerbated period were randomly divided into treatment group(60 cases) and control groups(60 cases).The treatment group by the conventional treatment plus Shuanghuanglian Injection while the control group only adopts conventional treatment,then make observation for both groups.ResultsIt showed that 49.1 percent for the clinical control rate of the treatment group while 38.3 percent of the control group.Total effective rate in the treatment group was 95.8% and 90.0% in the control group.ConclusionThe apparent high cure rate of pneumoconiosis of chronic obstructive pulmonary disease in the acute-exacerbated period by Shuanghuanglian Injection,and improve the situation quickly with lower chances of side effects,safe and reliable,it was worth to promoting the use among the primary health care units.
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©CNKI All Rights Reserved